Emtricitabine and tenofovir and Necitumumab Intravenous
Determining the interaction of Emtricitabine and tenofovir and Necitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: Emtricitabine and Tenofovir Disoproxil Fumarate
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emtricitabine and tenofovir-Necon
- Emtricitabine and tenofovir-Necon 0.5/35
- Emtricitabine and tenofovir-Necon 1/35
- Emtricitabine and tenofovir-Necon 1/50
- Emtricitabine and tenofovir-Necon 1/50 (28)
- Emtricitabine and tenofovir-Necon 7/7/7
- Necitumumab Intravenous-Emtricitabine and Tenofovir Alafenamide
- Necitumumab Intravenous-Emtricitabine and Tenofovir Disoproxil Fumarate
- Necitumumab Intravenous-Emtricitabine and Tenofovir Tablets
- Necitumumab Intravenous-Emtricitabine Capsules
- Necitumumab Intravenous-Emtricitabine Solution
- Necitumumab Intravenous-Emtricitabine, lopinavir, ritonavir, and tenofovir